Oncocyte Corp

Ownership Transactions Reported by 20 Insiders

Symbol
OCX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
15 Cushing, Irvine, California

Insiders trading volume in the past year

Oncocyte Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Broadwood Partners, L.P. 10%+ Owner $28.8M +$7.06M +32.5% Apr 11, 2024
Pura Vida Investments, Llc 10%+ Owner $3.04M Apr 14, 2023
Andrea James Chief Financial Officer $875K Jun 20, 2024
Andrew Arno Director $227K +$100K +78.9% Jul 1, 2024
John Peter Gutfreund Former Director $154K Jun 30, 2023
Ronald Asbury Andrews Former CEO, Director $125K Dec 1, 2022
Alfred D. Kingsley Director $109K Jun 23, 2023
Gisela Paulsen Former President and COO $78.8K Dec 16, 2022
Li Yu VP Cntrllr/Prncpl Acctng Offcr $76.5K May 18, 2022
Douglas Ross Former CSO $50.3K Dec 21, 2022
Cavan M. Redmond Director $26K Jun 24, 2022
Mitchell S. Levine Chief Financial Officer $18.7K Mar 15, 2022
Josh Riggs CEO and President, Director $10.3K +$10K +2950% May 20, 2024
Jennifer L. Carter Director $6.55K Aug 15, 2022
Melinda Griffith Director $6.45K Aug 15, 2022
Padmavathi Sundar Chief Commercial Officer Mar 15, 2022
Anish John Chief Financial Officer Feb 24, 2023
Lou Silverman Director Jul 1, 2024
James Liu Sr Dir., Cntlr, PAO, Int PFO May 20, 2024
Andrew J. Last Director Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Oncocyte Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.